| 摘要: |
| 斑蝥酸钠(disodium cantharidinate)为中药斑蝥的活性成分斑蝥素的衍生化合物。研究表明,斑蝥酸钠对肝癌、肺癌和乳腺癌等多种肿瘤细胞具有抑制作用,且毒性、刺激性较斑蝥素显著降低。作用机制可能与阻滞细胞周期、抑制增殖、促进凋亡和抑制肿瘤血管生成等有关。此外,以斑蝥酸钠为活性成分的抗癌注射剂(如:斑蝥酸钠注射液、斑蝥酸钠维生素B6注射液)在临床应用广泛,除抗肿瘤作用外,亦减轻化疗副作用。本文就斑蝥酸钠抗癌作用机制、临床应用及药物相互作用等方面进行总结,以期为斑蝥酸钠的进一步研究和临床再定位提供参考。 |
| 关键词: 斑蝥酸钠 注射剂 抗肿瘤 CYP450 |
| DOI:10.13506/j.cnki.jpr.2025.07.014 |
| 基金项目:北京市自然科学基金项目(No.7242249) |
|
|
|
| Research progress on the antitumor mechanism of disodium cantharidinate and the clinical application of its injection |
| YANG Yaxin1,2,ZHANG Fangbo1,CAI Qingqing1 |
| (1.Institute of Chinese Materia Medica,China Academy of Chinese Medical Sciences,Beijing 100700,China;2. Guizhou Baiqiang Pharmaceutical Co.,Ltd.,Guiyang 550005, China) |
| Abstract: |
| Disodium cantharidinate is a derivative compound of the active ingredient cantharidin in Mylabris. Research has demonstrated that disodium cantharidinate has demonstrated significant antitumor activity against various malignancies, including hepatocellular carcinoma, lung cancer, and breast cancer. Moreover, its toxicity and irritancy are markedly reduced compared to cantharidin. Its anticancer mechanisms are multifaceted, encompassing cell cycle arrest, inhibition proliferation, induction apoptosis, and suppression of tumor angiogenesis. Additionally, disodium cantharidinate-based formulations, such as disodium cantharidinate injection and disodium cantharidinate/vitamin B6 injection, are widely employed due to their dual role in exerting direct antitumor effects and alleviating chemotherapy-induced adverse reaction. This review aims tsummarize the anticancer mechanisms, clinical applications, and drug interactions of disodium cantharidinate, thereby providing a reference for further research and potential clinical repositioning. |
| Key words: Disodium cantharidinate Injection Anticancer CYP450 |